Genetic Technologies Ltd (GENE) Financials
GENE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 5.8 million | 2.5 million |
2023-09-30 | ? | ? |
2023-06-30 | 9.9 million | 2.5 million |
2023-03-31 | 10.0 million | 2.5 million |
GENE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -2.7 million | ? |
2023-09-30 | -13498 | ? |
2023-06-30 | -1.7 million | 84074 |
2023-03-31 | -691256 | 85049 |
GENE Net Income
No data available :(
GENE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 2.5 million | - | - |
2023-09-30 | - | - | - |
2023-06-30 | 5.2 million | - | 353505 |
2023-03-31 | 5.3 million | - | - |
GENE Shares Outstanding
GENE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 4769 | 265542 | - | - |
2023-09-30 | 13498 | - | - | - |
2023-06-30 | 7961 | 479560 | 189086 | 430296 |
2023-03-31 | 671 | 242561 | 191279 | 435286 |
GENE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.7 million | 4.0 million |
2023-09-30 | - | - |
2023-06-30 | 3.0 million | 3.8 million |
2023-03-31 | 1.8 million | 734067 |
GENE
Price: $2.29
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -14.82
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 666231
Ebitda: -5.8 millionMarket Capitalization: 10.7 million